Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-01-10

FDA Approved: VALTOCO — Original Application (Neurelis, Inc)

View source ↗

Summary

The FDA approved VALTOCO, a diazepam nasal spray from Neurelis, Inc., through an original NDA for the acute treatment of seizure clusters in patients with epile…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VALTOCO (diazepam nasal spray)

Snippet

ORIG AP for VALTOCO (DIAZEPAM)